Pubblicazioni

Orecchia P, Balza E, Pietra G, Conte R, Bizzarri N, Ferrero S, Mingari MC, Carnemolla B. L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model. Cancers (Basel). 2019;11(9). https://www.mdpi.com/2072-6694/11/9/1232

Ferrero S, Vellone VG, Barra F, Scala C. Ulipristal Acetate before Hysteroscopic and Laparoscopic Surgery for Uterine Myomas: Help or Hindrance? Gynecol Obstet Invest 2019;84:313-325. https://www.karger.com/Article/FullText/495347

Barra F, Romano A, Grandi G, Facchinetti F, Ferrero S. Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis. Expert Opin Investig Drugs 2019;28:501-504. https://www.tandfonline.com/doi/abs/10.1080/13543784.2019.1618269?journalCode=ieid20

Barra F, Ferro Desideri L, Ferrero S. Transforming growth factor β (TGF-β): is there a different role with regard to distinct phenotypes of endometriosis? Immunol Lett 2019;211:1-2. https://www.sciencedirect.com/science/article/abs/pii/S016524781930077X?via%3Dihub

Barra F, Scala C, Ferrero S. Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain. Drugs Today 2019;55:237-246. https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=2930713

Barra F, Laganà AS, Ghezzi F, Casarin J, Ferrero S. Nintedanib for Advanced Epithelial Ovarian Cancer: A Change of Perspective? Summary of Evidence from a Systematic Review. Gynecol Obstet Invest 2019;84:107-117. https://www.karger.com/Article/FullText/493361

Leone Roberti Maggiore U, Martinelli F, Dondi G, Bogani G, Chiappa V, Evangelista MT, Liberale V, Ditto A, Ferrero S, Raspagliesi F. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study. J Gynecol Oncol 2019;30:e57. https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e57

Grandi G, Barra F, Ferrero S, Facchinetti F. Estradiol in non-oral hormonal contraception: a “long and winding road”. Expert Rev Endocrinol Metab 201);14:153-155. https://www.tandfonline.com/doi/full/10.1080/17446651.2019.1604217

Barra F, Grandi G, Tantari M, Scala C, Facchinetti F, Ferrero S. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. Expert Opin Biol Ther 2019;19:343-360. https://www.tandfonline.com/doi/abs/10.1080/14712598.2019.1581761?journalCode=iebt20

Ditto A, Leone Roberti Maggiore U, Bogani G, Martinelli F, Chiappa V, Evangelista MT, Liberale V, Ferrero S, Raspagliesi F. Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer. Int J Gynaecol Obstet 2019;145:28-33. https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1002/ijgo.12769